Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CQ Pharmaceutical Holding CoSZSE:000950 77 Interest Coverage is 1.72 as of Jun. 2026, which is 28% below its 10-year median of 2.39. GuruFocus rates SZSE:000950 with a GF Score™ of 77/100 and a GF Value™ of ¥5.68 (Fairly Valued). The stock has 8 warning signs investors should review. Among 96 Medical Distribution companies, CQ Pharmaceutical Holding Co ranks worse than 78.13% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. CQ Pharmaceutical Holding Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥279 Mil. CQ Pharmaceutical Holding Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥-163 Mil.
CQ Pharmaceutical Holding Co's interest coverage for the quarter that ended in Jun. 2026 was 1.72.
The higher the ratio, the stronger the company's financial strength is.
Warning Sign:
Ben Graham prefers companies' interest coverage to be at least 5. CQ Pharmaceutical Holding Co Ltd interest coverage is 2.49, which is low.
The historical rank and industry rank for CQ Pharmaceutical Holding Co's Interest Coverage or its related term are showing as below:
SZSE:000950'
s Interest Coverage Range Over the Past 10 Years
Min: 0.87 Med: 2.39 Max: 5.04
Current: 2.49
SZSE:000950's Interest Coverage is ranked worse than 78.13% of 96
companies
in the Medical Distribution industry
Industry Median: 7.215
vs SZSE:000950: 2.49
CQ Pharmaceutical Holding Co (SZSE:000950) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
CQ Pharmaceutical Holding Co Interest Coverage Related Terms
CQ Pharmaceutical Holding Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
CQ Pharmaceutical Holding Co Interest Coverage Chart
SZSE:000950 vs MCK, COR, CAH: Interest Coverage Comparison
For the Medical Distribution subindustry, CQ Pharmaceutical Holding Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CQ Pharmaceutical Holding Co Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CQ Pharmaceutical Holding Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where CQ Pharmaceutical Holding Co's Interest Coverage falls into.
CQ Pharmaceutical Holding Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CQ Pharmaceutical Holding Co (SZSE:000950) has a Interest Coverage of 1.72 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on CQ Pharmaceutical Holding Co and its competitors. This is 28% below median its historical median of 2.39. Over the past decade, CQ Pharmaceutical Holding Co's Interest Coverage has ranged from 0.87 to 5.04. According to the industry distribution chart, CQ Pharmaceutical Holding Co ranks #75 out of 96 companies in the Medical Distribution industry, placing it in the top 78.1%.
Is CQ Pharmaceutical Holding Co's Interest Coverage too high?
CQ Pharmaceutical Holding Co's current Interest Coverage of 1.72 is 28% below median its 10-year median of 2.39. Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 5.04. The Medical Distribution industry median Interest Coverage is 7.22. CQ Pharmaceutical Holding Co's value of 1.72 is 76.2% below this industry median. Based on the distribution chart, CQ Pharmaceutical Holding Co ranks #75 out of 96 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, CQ Pharmaceutical Holding Co has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CQ Pharmaceutical Holding Co's Interest Coverage compare to MCK and COR?
According to the Medical Distribution industry distribution chart, CQ Pharmaceutical Holding Co ranks #75 out of 96 companies for Interest Coverage. This places CQ Pharmaceutical Holding Co in the lower half of its industry. The industry median Interest Coverage is 7.22. CQ Pharmaceutical Holding Co's value of 1.72 is 76.2% below this benchmark. Historically, CQ Pharmaceutical Holding Co's own Interest Coverage has ranged from 0.87 to 5.04 over the past decade. While the company's 10-year median is 2.39 vs. the industry median of 7.22, CQ Pharmaceutical Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 7.22, based on 96 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CQ Pharmaceutical Holding Co's current Interest Coverage of 1.72 is 76.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on CQ Pharmaceutical Holding Co and its competitors. For the Medical Distribution industry, the median Interest Coverage is 7.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CQ Pharmaceutical Holding Co's current Interest Coverage is 1.72, which is 28% below median its own 10-year median of 2.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CQ Pharmaceutical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co (SZSE:000950) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.68, compared to a current price of ¥5.17 — trading 9% below its estimated fair value. The current Interest Coverage is 1.72, which is 28% below median its 10-year median of 2.39 and 76.2% below the Medical Distribution industry median of 7.22. CQ Pharmaceutical Holding Co's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For CQ Pharmaceutical Holding Co (SZSE:000950), the current Interest Coverage is 1.72 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CQ Pharmaceutical Holding Co (SZSE:000950) Overvalued in 2026?
Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co stock appears to be undervalued.
The current stock price of ¥5.17 is trading 9% below its estimated GF Value™ of ¥5.68.
GuruFocus considers CQ Pharmaceutical Holding Co to be Fairly Valued.
Key valuation signals for SZSE:000950:
Interest Coverage: 1.72 (28% below median its 10-year median of 2.39)
GF Value™: ¥5.68 vs. price of ¥5.17 (9% below fair value)
Industry Position: 76.2% below the Medical Distribution median (#75 of 96)
No single metric tells the full story. See the SZSE:000950 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.
77GF Score
Get the complete analysis for SZSE:000950
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000950 has been successfully added to your 
